Tae Won Choi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Tae Won Choi has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Jae Seung Bang
Department of Neurosurgery, Seoul National University Bundang Hospital, Seongnam, Republic of Korea
2 shared publications - Sang Hyo Lee
Department of Neurosurgery, Seoul National University Bundang Hospital, Seongnam, Republic of Korea
2 shared publications - Seung Pil Ban
Departments of Neurosurgery, Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea
2 shared publications - Si Un Lee
Department of Neurosurgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam-si, Republic of Korea
2 shared publications - Chang Wan Oh
Department of Neurosurgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea
1 shared publication - Dae Jean Jo
Department of Neurosurgery, Kyung Hee University Hospital at Gangdong, Kyung Hee University College of Medicine, Seoul 05278, Republic of Korea
1 shared publication
Latest Publications
- 10 October 2025
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 99 (1) , 113-121
Comparison of Triple Antiplatelet (Aspirin, Clopidogrel, and Cilostazol) and Modified Dual Antiplatelet (Aspirin and Low-Dose Prasugrel) Therapy in Patients With High On-Treatment Platelet Reactivity Undergoing Stent-Assisted Coil Embolization for an Unruptured Intracranial Aneurysm: A Prospective Randomized Clinical Trial
BACKGROUND AND OBJECTIVES: Modified antiplatelet therapies in patients with high on-treatment platelet reactivity (HTPR) remains unknown in neurointerventional treatment. We aimed to compare the safety and effectiveness of two different modified antiplatelet therapies in patients with HTPR undergoing stent-assisted coil embolization for an unruptured intracranial aneurysm. METHODS: We conducted a prospective, randomized clinical trial. Participants with HTPR were randomly assigned (1:1) to the triple antiplatelet therapy (TAT, addition of cilostazol) or modified dual antiplatelet therapy (MDAT, switched from clopidogrel to low-dose prasugrel) group. The primary outcome was all-bleeding-events during the 90-day follow-up period. The secondary outcomes were thromboembolic events and changes in the P2Y12 reaction unit (PRU) value throughout the follow-up period. Intention-to-treat (ITT) and per-protocol (PP) analyses were performed. RESULTS: In total, 172 of the 198 participants maintained initial antiplatelet therapy for 90 days. There was no significant difference in the all-bleeding-event rate between the two groups, both in the ITT population (hazard ratio [HR], 0.77 [95% CI, 0.49-1.20]; P = .26) and the PP population (HR, 0.79 [95% CI, 0.50-1.30]; P = .34). The thromboembolic event rate did not differ between the 2 groups in either the ITT population (HR, 0.33 [95% CI, 0.03-3.20]; P = .34) or the PP population (HR, 0.42 [95% CI, 0.04-4.70]; P = .48). Compared with those in the TAT group, the PRU values in the MDAT group greatly decreased over time, particularly for PRU after loading. CONCLUSION: Among patients with HTPR who underwent stent-assisted coil embolization for an unruptured intracranial aneurysm, there was no significant difference between the TAT and MDAT groups regarding the risk of all bleeding events and thromboembolic events during the 90 days of follow-up.
- 10 October 2025
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 99 (1) , 113-121
Comparison of Triple Antiplatelet (Aspirin, Clopidogrel, and Cilostazol) and Modified Dual Antiplatelet (Aspirin and Low-Dose Prasugrel) Therapy in Patients With High On-Treatment Platelet Reactivity Undergoing Stent-Assisted Coil Embolization for an Unruptured Intracranial Aneurysm: A Prospective Randomized Clinical Trial
BACKGROUND AND OBJECTIVES: Modified antiplatelet therapies in patients with high on-treatment platelet reactivity (HTPR) remains unknown in neurointerventional treatment. We aimed to compare the safety and effectiveness of two different modified antiplatelet therapies in patients with HTPR undergoing stent-assisted coil embolization for an unruptured intracranial aneurysm. METHODS: We conducted a prospective, randomized clinical trial. Participants with HTPR were randomly assigned (1:1) to the triple antiplatelet therapy (TAT, addition of cilostazol) or modified dual antiplatelet therapy (MDAT, switched from clopidogrel to low-dose prasugrel) group. The primary outcome was all-bleeding-events during the 90-day follow-up period. The secondary outcomes were thromboembolic events and changes in the P2Y12 reaction unit (PRU) value throughout the follow-up period. Intention-to-treat (ITT) and per-protocol (PP) analyses were performed. RESULTS: In total, 172 of the 198 participants maintained initial antiplatelet therapy for 90 days. There was no significant difference in the all-bleeding-event rate between the two groups, both in the ITT population (hazard ratio [HR], 0.77 [95% CI, 0.49-1.20]; P = .26) and the PP population (HR, 0.79 [95% CI, 0.50-1.30]; P = .34). The thromboembolic event rate did not differ between the 2 groups in either the ITT population (HR, 0.33 [95% CI, 0.03-3.20]; P = .34) or the PP population (HR, 0.42 [95% CI, 0.04-4.70]; P = .48). Compared with those in the TAT group, the PRU values in the MDAT group greatly decreased over time, particularly for PRU after loading. CONCLUSION: Among patients with HTPR who underwent stent-assisted coil embolization for an unruptured intracranial aneurysm, there was no significant difference between the TAT and MDAT groups regarding the risk of all bleeding events and thromboembolic events during the 90 days of follow-up.
- Open Access
- 1 January 2024
- Published by XMLink in Journal of Korean Medical Science
- Vol. 39 (23) , e188
Clinical Outcomes of Clipping and Coil Embolization for Ruptured Intracranial Aneurysms Categorized by Region and Hospital Size: A Nationwide Cohort Study in Korea
Won YD, et al. J Korean Med Sci. 2024 May;39:e188. https://doi.org/10.3346/jkms.2024.39.e188
- 1 January 2024
- Published by XMLink in Journal of Korean Medical Science
- Vol. 39 (23) , e188
Open AccessClinical Outcomes of Clipping and Coil Embolization for Ruptured Intracranial Aneurysms Categorized by Region and Hospital Size: A Nationwide Cohort Study in Korea
Won YD, et al. J Korean Med Sci. 2024 May;39:e188. https://doi.org/10.3346/jkms.2024.39.e188
- Open Access
- 31 October 2021
- Published by The Korean Society of Geriatric Neurosurgery in Journal of Korean Society of Geriatric Neurosurgery
- Vol. 17 (2) , 64-68
Annuloplasty as a method to prevent recurrent herniation of lumbar intervertebral discs
- 31 October 2021
- Published by The Korean Society of Geriatric Neurosurgery in Journal of Korean Society of Geriatric Neurosurgery
- Vol. 17 (2) , 64-68
Open AccessAnnuloplasty as a method to prevent recurrent herniation of lumbar intervertebral discs
- Open Access
- 31 October 2021
- Published by The Korean Society of Geriatric Neurosurgery in Journal of Korean Society of Geriatric Neurosurgery
- Vol. 17 (2) , 76-79
Reversible cerebral vasoconstriction syndrome presenting with intracranial hemorrhage: a case report and literature review
- 31 October 2021
- Published by The Korean Society of Geriatric Neurosurgery in Journal of Korean Society of Geriatric Neurosurgery
- Vol. 17 (2) , 76-79
Open AccessReversible cerebral vasoconstriction syndrome presenting with intracranial hemorrhage: a case report and literature review
- 1 January 2016
- Published by Hikari, Ltd. in Contemporary Engineering Sciences
- Vol. 9, 547-552
Human detection in top-view depth image
- 1 January 2016
- Published by Hikari, Ltd. in Contemporary Engineering Sciences
- Vol. 9, 547-552
Human detection in top-view depth image